[Can the anti-androgenic effect of spironolactone contraindicate its use in pregnancy?].
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000726:Androgen Antagonists; D000728:Androgens / Q000096:biosynthesis; D000818:Animals; D005260:Female; D005333:Fetus / Q000187:drug effects; D005837:Genitalia, Male / Q000002:abnormalities*; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D008297:Male; D011247:Pregnancy; D051381:Rats; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use
D000726:Androgen Antagonists; D000728:Androgens; D013148:Spironolactone
L'effetto antiandrogeno dello spironolattone può controindicarne l'impiego in gravidanza?